On February 28, 2024, as the International Rare Diseases Day 2024 approaches, Frost & Sullivan (Frost & Sullivan, referred to as 'Frost & Sullivan') and the Beijing Pain Relief Challenge Public Welfare Foundation (referred to as 'Pain Relief Challenge Foundation') jointly released the '2024 China Rare Diseases Industry Trend Observation Report'. The '2024 China Rare Diseases Industry Trend Observation Report' is the third annual trend observation report following the joint release of the '2023 China Rare Diseases Industry Trend Observation Report' and the '2022 China Rare Diseases Industry Trend Observation Report' by Frost & Sullivan in collaboration with the Pain Relief Challenge Foundation.
The Report aims to review and sort out the new progress made in China's rare disease field in 2023, covering aspects such as policy support, diagnosis and treatment, special medical foods, drug research and development, investment and mergers and acquisitions, and development prospects. It provides a comprehensive overview of the progress made in this field in 2023 and the industry challenges it faces. It also sets out prospects for China's comprehensive rare disease service system, offering an industry panorama to all sectors of society. It is hoped that this will be beneficial to policymakers, advocates, practitioners from relevant institutions, patients with rare diseases and their families, and other stakeholders in the field of rare diseases.
